You are here
Table of Contents
Chapters
- AIDS and HIV
- Addiction and Dependence
- Adolescents
- Alcohol
- Amphetamine-Type Stimulants
- Arrests and Criminal Law Enforcement
- Buprenorphine
- CBD (Cannabidiol)
- Cannabis
- Capital Punishment for Drug Offenses
- Causes of Death
- Chronic Pain
- Civil & Human Rights
- Cocaine, Crack, and Coca
- Corruption
- Crime
- Dark Net Drug Markets & Cryptomarkets
- Death Penalty
- Demand Reduction
- Diversion of Drugs
- Driving and Drugs
- Drug Checking for Contaminants
- Drug Courts
- Drug Policies & Policy Reform
- Drug Use Estimates: Prevalence and Trends
- Drug Use Testing Overview
- Drug Use Testing Related To Employment
- Drug Use Testing Related To Schools
- Drugs & the Correctional System
- Economics
- Ecstasy (MDMA)
- Entheogens & Psychedelics
- Environment
- Families
- Fentanyl
- Forfeiture
- Gateway Hypothesis
- Harm Reduction
- Hemp
- Hepatitis C
- Heroin
- Heroin Treatment
- Ibogaine
- HIV and People Who Inject Drugs
- Injection Drug Use, Race, and HIV
- Interdiction
- International
- Jails
- Kratom
- Mandatory Minimums
- Marijuana
- Medical Marijuana
- Medication for Opioid Use Disorder
- Mental Health Medications (Psychotropics)
- Mental Health and Substance Use
- Methadone
- Methamphetamine
- Militarization
- Mushrooms (Psilocybin)
- Naloxone
- Netherlands vs US
- New Psychoactive Substances
- Opioid Treatment
- Overdose
- Overdose Crisis
- Overdose Prevention Sites
- Pain Management
- People Who Inject Drugs
- Policies and Policy Reform
- Pregnancy and Substance Use
- Prescription Drug Monitoring Programs
- Prevalence of Substance Use
- Prevention
- Prisons, Jails, Probation and Parole
- Prisons and Drugs
- Prisons and Race
- Psilocybin (Magic Mushrooms)
- Psychotropic Medications
- Race and Injection Drug Use
- Race and Prisons
- Recovery and Social Reintegration
- Stimulants
- Supervised Consumption Facilities
- Supply Reduction
- Syringe Service and Needle Exchange Programs
- Testing for Alcohol and Other Drugs
- Tobacco & Nicotine
- Treatment for Substance Use Disorders
- Vivitrol
- Women
- Young People and Substance Use